), assists to elucidate why KIF15 has the capacity to aid resistance to Eg5 inhibitors in vivo. MT gliding powered by both equally of these mitotic motors was arrested only if they had been individually inhibited, lending support to your proposal that a mix drug therapy targeting these motors may be